Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: Results of a prospective study in a clinical setting

Giorgio Guazzoni, Luciano Nava, Massimo Lazzeri, Vincenzo Scattoni, Giovanni Lughezzani, Carmen MacCagnano, Fernanda Dorigatti, Ferruccio Ceriotti, Marina Pontillo, Vittorio Bini, Massimo Freschi, Francesco Montorsi, Patrizio Rigatti

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: Results of a prospective study in a clinical setting'. Together they form a unique fingerprint.

Medicine & Life Sciences